1. Short title This Act may be cited as the Lower Costs, More Cures Act of 2019 . 2. Table of contents The table of contents for this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. TITLE I—Medicare Parts B and D Subtitle A—Medicare Part B Provisions Sec. 101. Improvements to Medicare site-of-service transparency. Sec. 102. Requiring manufacturers of certain single-dose container or single-use package drugs payable under part B of the Medicare program to provide refunds with respect to discarded amounts of such drugs. Sec. 103. Providing for variation in payment for certain drugs covered under part B of the Medicare program. Sec. 104. Establishment of maximum add-on payment for drugs and biologicals. Sec. 105. Treatment of drug administration services furnished by certain excepted off-campus outpatient departments of a provider. Sec. 106. Payment for biosimilar biological products during initial period. Sec. 107. Education on biological and biosimilar products. Sec. 108. GAO study and report on average sales price. Subtitle B—Medicare Part D Provisions Sec. 111. Medicare part D benefit redesign. Sec. 112. Transitional coverage and retroactive Medicare part D coverage for certain low-income beneficiaries. Sec. 113. Allowing the offering of additional prescription drug plans under Medicare part D. Sec. 114. Allowing certain enrollees of prescription drug plans and MA–PD plans under the Medicare program to spread out cost-sharing under certain circumstances. Sec. 115. Establishing a monthly cap on beneficiary incurred costs for insulin products and supplies under a prescription drug plan or MA–PD plan. Sec. 116. Growth rate of Medicare part D out-of-pocket cost threshold. Sec. 117. Requiring prescription drug plan sponsors to include real-time benefit information as part of such sponsor’s electronic prescription program under the Medicare program. Sec. 118. Requiring prescription drug plans and MA–PD plans to report potential fraud, waste, and abuse to the Secretary of HHS. Sec. 119.